Literature DB >> 31134826

Hydrogen sulphide promotes osteoclastogenesis by inhibiting autophagy through the PI3K/AKT/mTOR pathway.

Jun Ma1, Di Du1, Jia Liu1, Lei Guo2, Yongchuan Li1, Aimin Chen1, TianWen Ye1.   

Abstract

Hydrogen sulphide (H2S), a gasotransmitter, plays an important role in the regulation of bone homeostasis. However, the precise effect of H2S on osteoclasts was still elusive. The goal of this study was to determine the potential role of H2S in regulation of osteoclasts and the underlying mechanisms by which H2S affected osteoclastogenesis. The present study applied western blot, quantitative real-time PCR, tartrate-resistant acid phosphatase staining, pit formation assay, immunofluorescence confocal microscopy, transmission electron microscopy and annexin V-fluorescein isothiocyanate/propidium iodide double-staining assay. The results showed that the expressions of cystathionine b-synthase (CBS) and cystathionine c-lyase (CSE) were obviously increased in osteoclast differentiation induced by the receptor activator of nuclear factor kappa-β ligand (RANKL). In addition, H2S promoted RANKL-induced osteoclastogenesis and inhibited apoptosis of mature osteoclasts. Mechanistically, H2S inhibited autophagy in Raw 264.7 cells. Autophagy activator (rapamycin) alleviated the induction of osteoclast differentiation by H2S. Further studies showed that H2S inhibited autophagy by activating the PI3K/AKT/mTOR signalling pathway. Taken together, our results implicated that exogenous H2S could promote osteoclastogenesis by activating the PI3K/AKT/mTOR pathway to downregulate autophagy.

Entities:  

Keywords:  Hydrogen sulphide; PI3K/AKT/mTOR; autophagy; osteoclastogenesis

Mesh:

Substances:

Year:  2019        PMID: 31134826     DOI: 10.1080/1061186X.2019.1624969

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  9 in total

Review 1.  Emerging roles of cystathionine β-synthase in various forms of cancer.

Authors:  Kelly Ascenção; Csaba Szabo
Journal:  Redox Biol       Date:  2022-05-10       Impact factor: 10.787

2.  Metformin Facilitates Osteoblastic Differentiation and M2 Macrophage Polarization by PI3K/AKT/mTOR Pathway in Human Umbilical Cord Mesenchymal Stem Cells.

Authors:  Min Shen; Huihui Yu; Yunfeng Jin; Jiahang Mo; Jingni Sui; Xiaohan Qian; Tong Chen
Journal:  Stem Cells Int       Date:  2022-06-18       Impact factor: 5.131

3.  Ferric Ion Induction of Triggering Receptor Expressed in Myeloid Cells-2 Expression and PI3K/Akt Signaling Pathway in Preosteoclast Cells to Promote Osteoclast Differentiation.

Authors:  Lu-Lin Liu; Zi-Hou Cao; Chun-Lei He; Yan-Chun Zhong; Wu-Yang Liu; Peng Zhang; Fan Yang; You-Jia Xu
Journal:  Orthop Surg       Date:  2020-07-30       Impact factor: 2.071

4.  Hydrogen sulfide facilitates reprogramming and trans-differentiation in 3D dermal fibroblast.

Authors:  Elena A Ostrakhovitch; Shin Akakura; Siamak Tabibzadeh
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

Review 5.  Hydrogen sulfide in ageing, longevity and disease.

Authors:  Stephen E Wilkie; Gillian Borland; Roderick N Carter; Nicholas M Morton; Colin Selman
Journal:  Biochem J       Date:  2021-10-15       Impact factor: 3.857

Review 6.  Progress of Signaling Pathways, Stress Pathways and Epigenetics in the Pathogenesis of Skeletal Fluorosis.

Authors:  Lichun Qiao; Xuan Liu; Yujie He; Jiaheng Zhang; Hao Huang; Wenming Bian; Mumba Mulutula Chilufya; Yan Zhao; Jing Han
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

Review 7.  Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells.

Authors:  Huarui Cai; Zhongze Wang; Wenhan Tang; Xiaoxue Ke; Erhu Zhao
Journal:  Front Genet       Date:  2022-08-30       Impact factor: 4.772

8.  Hydrogen sulfide is a novel regulator implicated in glucocorticoids-inhibited bone formation.

Authors:  Jun Ma; Changgui Shi; Zhongyang Liu; Bin Han; Lei Guo; Lei Zhu; Tianwen Ye
Journal:  Aging (Albany NY)       Date:  2019-09-16       Impact factor: 5.682

9.  Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.

Authors:  Wenli Jiang; Youlutuziayi Rixiati; Hao Huang; YiJun Shi; Caiguo Huang; Binghua Jiao
Journal:  Cancer Med       Date:  2020-09-25       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.